Achillion Pharmaceuticals (ACHN) 10.99 $ACHN
Nasdaq stocks posting largest percentage decreases
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
CENX: 16.49 (-0.02), BRLI: 33.71 (-2.80), CECE: 12.78 (-1.77), ACHN: 10.99 (-0.64), XPLR: 6.08 (-0.14), FISH: 20.22 (+0.31), BOBE: 47.76 (+1.40), CCRN: 10.96 (-1.23), AMED: 28.35 (-1.08), MTEX: 18.00 (-0.77), SMTC: 26.30 (-2.99)
Most active Nasdaq-traded stocks
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 29.28 (+0.02), PCYC: 254.22 (+23.74), FB: 81.21 (+0.32), INTC: 33.73 (-0.39), ATML: 8.80 (-0.02), OREX: 8.01 (-0.48), FOX: 34.03 (-0.04), ACHN: 10.99 (-0.64), FOXA: 34.87 (-0.10), MSFT: 43.11 (+0.05), AAPL: 126.41 (-2.13), CSCO: 29.30 (-0.03)
Achillion Pharmaceuticals (ACHN) Stock Tanking Today on Heavy Volume
at The Street - Thu Mar 05, 12:22PM CST
Achillion Pharmaceuticals (ACHN) stock is sharply lower this afternoon on heavy trading volume.
ACHN: 10.99 (-0.64)
Achillion Pharma updates guidance after Q4 results
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 8:20AM CST
ACHN: 10.99 (-0.64)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 8:15AM CST
JOY: 39.94 (-2.19), EYES: 17.07 (+2.16), KR: 74.31 (+4.66), PCYC: 254.22 (+23.74), ONCY: 1.05 (+0.04), NAVB: 1.70 (+0.08), ERJ: 33.33 (-1.57), MVIS: 2.38 (+0.28), ARWR: 7.94 (+0.43), ASTI: 1.45 (+0.11), CLDN: 21.46 (+1.82), TGTX: 15.59 (+0.74), NVGN: 2.98 (-0.38), VSLR: 11.35 (+2.82), ACHN: 10.99 (-0.64), KYTH: 50.00 (+10.10), AVEO: 1.42 (-0.12), PEIX: 11.75 (+2.42), IFON: 2.52 (-0.19)
Should You Sell Achillion Pharmaceuticals (ACHN) Before Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 7:30AM CST
Achillion Pharmaceuticals has earnings coming up pretty soon, and events are shaping up quite nicely for their report
ACHN: 10.99 (-0.64)
Achillion Pharmaceuticals misses by $0.03
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 6:21AM CST
ACHN: 10.99 (-0.64)
Achillion reports 4Q loss
Automated Insights - Thu Mar 05, 5:43AM CST
NEW HAVEN, Conn. (AP) _ Achillion Pharmaceuticals Inc. (ACHN) on Thursday reported a loss of $21.6 million in its fourth quarter.
ACHN: 10.99 (-0.64)
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.91 (-0.04), VRX: 203.95 (+0.80), ACT: 295.70 (-0.44), PCYC: 254.22 (+23.74), MDT: 78.50 (+0.31), CAH: 88.95 (-0.08), CLDX: 29.78 (+0.48), HSP: 87.85 (-0.10), AGN: 235.41 (-0.27), JNJ: 102.52 (+0.87), ATOS: 2.01 (-0.02), ONVO: 5.72 (-0.15), PTCT: 72.72 (+2.26), SNY: 48.36 (+0.02), PTLA: 41.85 (-1.03), INCY: 91.97 (+4.06), PFE: 34.47 (-0.17), CPHR: 12.00 (+0.22), MYL: 56.69 (+1.09), AMGN: 159.60 (+0.41), LLY: 70.59 (-0.06), BMY: 66.05 (+0.38), MNKD: 5.73 (-0.21), NKTR: 13.30 (-0.09), OMER: 26.35 (+0.15), DVA: 76.93 (+0.18), GILD: 103.42 (+0.36), SGEN: 35.60 (+0.48), ACHN: 10.99 (-0.64), MRK: 57.98 (+0.10), TEVA: 56.51 (-0.05), BIL: 45.73 (unch), ARIA: 8.25 (+0.15), NVS: 98.95 (-0.09)
Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BRLI: 33.71 (-2.80), CASM: 1.37 (+0.03), AMRN: 1.67 (-0.02), XON: 49.50 (+1.39), OSIR: 16.94 (-0.86), CPIX: 6.75 (+0.12), AMED: 28.35 (-1.08), CTIC: 2.72 (+0.26), INSY: 57.61 (-0.46), ECYT: 6.25 (-0.48), CMRX: 40.79 (+0.05), KYTH: 50.00 (+10.10), TRIB: 18.52 (-0.08), GALE: 2.00 (+0.05), ARNA: 4.23 (-0.09), XLRN: 41.34 (+0.33), ACRX: 9.01 (-0.10), ENDP: 87.71 (+2.06), DPLO: 30.48 (-0.30), SLXP: 157.44 (+0.31), PPHM: 1.57 (+0.10), MYL: 56.69 (+1.09), CBPO: 81.80 (+2.09), RGEN: 25.78 (+0.67), HALO: 15.39 (-0.31), ALIM: 4.90 (-0.31), ACHN: 10.99 (-0.64), GERN: 3.78 (+0.97), DARA: 0.82 (-0.03), SCMP: 15.15 (+0.33), ICPT: 261.18 (-5.31), CDXS: 3.99 (+0.09), PCRX: 98.40 (+3.01), PBYI: 243.17 (+36.21), FOLD: 8.65 (+0.24)
Achillion: The Dark Side
Kanak Kanti De - at Seeking Alpha - Fri Feb 27, 5:45AM CST
GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), ABBV: 56.86 (-3.41)
3 Tiny Biotech Stocks That I'm Paying Attention to in 2015
Todd Campbell, The Motley Fool - Motley Fool - Sun Feb 22, 7:02AM CST
The fact that biotech stocks can trade up or down significantly based on news from clinical research trials ensures there is no shortage of pop-and-drop stories in this business. The industry's volatility might scare off many investors, but for those...
GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), PRTA: 26.58 (+0.41), CUR: 3.77 (+0.10)
Achillion Pharmaceuticals completes public offering at USD10.25 per share
M2 - Thu Feb 19, 4:35AM CST
Pharmaceutical company Achillion Pharmaceuticals (NasdaqGS:ACHN) reported on Wednesday the completion of its public offering of 13,800,000 common stock at USD10.25 per share.
ACHN: 10.99 (-0.64)
Achillion completes equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 3:48PM CST
ACHN: 10.99 (-0.64)
Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock
GlobeNewswire - Wed Feb 18, 3:35PM CST
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today the closing of its previously announced public offering of common stock. Achillion sold 13,800,000 shares of its common stock in the offering at a price to the public of $10.25 per share, including the exercise in full by the underwriters of their option to purchase an additional 1,800,000 shares of common stock at the public offering price. Achillion received net proceeds of approximately $132.7 million, after deducting underwriting discounts and commissions and estimated offering expenses.
ACHN: 10.99 (-0.64), WFC: 54.84 (+0.02)
Is Gilead Sciences Inc. Stock Cheap Now?
George Budwell, The Motley Fool - Motley Fool - Wed Feb 18, 7:59AM CST
The stock market doesn't always make sense or act on rational terms. Sometimes good stocks are sold off for little or no reason. That appears to be the case with Gilead Sciences . Gilead's shares have tanked due to pricing pressure from AbbVie...
JNJ: 102.52 (+0.87), GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), PFE: 34.47 (-0.17), ABBV: 56.86 (-3.41), CELG: 120.71 (+1.14)
Hep C Franchise Will Remain Key Midterm Driver For Gilead
Kanak Kanti De - at Seeking Alpha - Tue Feb 17, 12:34PM CST
JNJ: 102.52 (+0.87), GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), ABBV: 56.86 (-3.41)
Achillion Pharmaceuticals: A Strong Contender In A Crowded Space
DoconStocks - at Seeking Alpha - Tue Feb 17, 7:53AM CST
GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), MRK: 57.98 (+0.10), ABBV: 56.86 (-3.41)
Emergent BioSolutions Reports Positive Data on BioThrax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 3:10PM CST
Emergent BioSolutions Inc. (EBS) announced encouraging data from a pivotal non-clinical efficacy study on BioThrax.
BMRN: 113.50 (+3.71), EBS: 29.24 (-0.24), ALNY: 111.56 (+4.33), ACHN: 10.99 (-0.64)
Nasdaq stocks posting largest percentage decreases
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
CENX: 16.49 (-0.02), BRLI: 33.71 (-2.80), CECE: 12.78 (-1.77), ACHN: 10.99 (-0.64), XPLR: 6.08 (-0.14), FISH: 20.22 (+0.31), BOBE: 47.76 (+1.40), CCRN: 10.96 (-1.23), AMED: 28.35 (-1.08), MTEX: 18.00 (-0.77), SMTC: 26.30 (-2.99)
Most active Nasdaq-traded stocks
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 29.28 (+0.02), PCYC: 254.22 (+23.74), FB: 81.21 (+0.32), INTC: 33.73 (-0.39), ATML: 8.80 (-0.02), OREX: 8.01 (-0.48), FOX: 34.03 (-0.04), ACHN: 10.99 (-0.64), FOXA: 34.87 (-0.10), MSFT: 43.11 (+0.05), AAPL: 126.41 (-2.13), CSCO: 29.30 (-0.03)
Achillion Pharmaceuticals (ACHN) Stock Tanking Today on Heavy Volume
at The Street - Thu Mar 05, 12:22PM CST
Achillion Pharmaceuticals (ACHN) stock is sharply lower this afternoon on heavy trading volume.
ACHN: 10.99 (-0.64)
Achillion Pharma updates guidance after Q4 results
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 8:20AM CST
ACHN: 10.99 (-0.64)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 8:15AM CST
JOY: 39.94 (-2.19), EYES: 17.07 (+2.16), KR: 74.31 (+4.66), PCYC: 254.22 (+23.74), ONCY: 1.05 (+0.04), NAVB: 1.70 (+0.08), ERJ: 33.33 (-1.57), MVIS: 2.38 (+0.28), ARWR: 7.94 (+0.43), ASTI: 1.45 (+0.11), CLDN: 21.46 (+1.82), TGTX: 15.59 (+0.74), NVGN: 2.98 (-0.38), VSLR: 11.35 (+2.82), ACHN: 10.99 (-0.64), KYTH: 50.00 (+10.10), AVEO: 1.42 (-0.12), PEIX: 11.75 (+2.42), IFON: 2.52 (-0.19)
Should You Sell Achillion Pharmaceuticals (ACHN) Before Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 7:30AM CST
Achillion Pharmaceuticals has earnings coming up pretty soon, and events are shaping up quite nicely for their report
ACHN: 10.99 (-0.64)
Achillion Pharmaceuticals misses by $0.03
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 6:21AM CST
ACHN: 10.99 (-0.64)
Achillion reports 4Q loss
Automated Insights - Thu Mar 05, 5:43AM CST
NEW HAVEN, Conn. (AP) _ Achillion Pharmaceuticals Inc. (ACHN) on Thursday reported a loss of $21.6 million in its fourth quarter.
ACHN: 10.99 (-0.64)
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.91 (-0.04), VRX: 203.95 (+0.80), ACT: 295.70 (-0.44), PCYC: 254.22 (+23.74), MDT: 78.50 (+0.31), CAH: 88.95 (-0.08), CLDX: 29.78 (+0.48), HSP: 87.85 (-0.10), AGN: 235.41 (-0.27), JNJ: 102.52 (+0.87), ATOS: 2.01 (-0.02), ONVO: 5.72 (-0.15), PTCT: 72.72 (+2.26), SNY: 48.36 (+0.02), PTLA: 41.85 (-1.03), INCY: 91.97 (+4.06), PFE: 34.47 (-0.17), CPHR: 12.00 (+0.22), MYL: 56.69 (+1.09), AMGN: 159.60 (+0.41), LLY: 70.59 (-0.06), BMY: 66.05 (+0.38), MNKD: 5.73 (-0.21), NKTR: 13.30 (-0.09), OMER: 26.35 (+0.15), DVA: 76.93 (+0.18), GILD: 103.42 (+0.36), SGEN: 35.60 (+0.48), ACHN: 10.99 (-0.64), MRK: 57.98 (+0.10), TEVA: 56.51 (-0.05), BIL: 45.73 (unch), ARIA: 8.25 (+0.15), NVS: 98.95 (-0.09)
Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BRLI: 33.71 (-2.80), CASM: 1.37 (+0.03), AMRN: 1.67 (-0.02), XON: 49.50 (+1.39), OSIR: 16.94 (-0.86), CPIX: 6.75 (+0.12), AMED: 28.35 (-1.08), CTIC: 2.72 (+0.26), INSY: 57.61 (-0.46), ECYT: 6.25 (-0.48), CMRX: 40.79 (+0.05), KYTH: 50.00 (+10.10), TRIB: 18.52 (-0.08), GALE: 2.00 (+0.05), ARNA: 4.23 (-0.09), XLRN: 41.34 (+0.33), ACRX: 9.01 (-0.10), ENDP: 87.71 (+2.06), DPLO: 30.48 (-0.30), SLXP: 157.44 (+0.31), PPHM: 1.57 (+0.10), MYL: 56.69 (+1.09), CBPO: 81.80 (+2.09), RGEN: 25.78 (+0.67), HALO: 15.39 (-0.31), ALIM: 4.90 (-0.31), ACHN: 10.99 (-0.64), GERN: 3.78 (+0.97), DARA: 0.82 (-0.03), SCMP: 15.15 (+0.33), ICPT: 261.18 (-5.31), CDXS: 3.99 (+0.09), PCRX: 98.40 (+3.01), PBYI: 243.17 (+36.21), FOLD: 8.65 (+0.24)
Achillion: The Dark Side
Kanak Kanti De - at Seeking Alpha - Fri Feb 27, 5:45AM CST
GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), ABBV: 56.86 (-3.41)
3 Tiny Biotech Stocks That I'm Paying Attention to in 2015
Todd Campbell, The Motley Fool - Motley Fool - Sun Feb 22, 7:02AM CST
The fact that biotech stocks can trade up or down significantly based on news from clinical research trials ensures there is no shortage of pop-and-drop stories in this business. The industry's volatility might scare off many investors, but for those...
GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), PRTA: 26.58 (+0.41), CUR: 3.77 (+0.10)
Achillion Pharmaceuticals completes public offering at USD10.25 per share
M2 - Thu Feb 19, 4:35AM CST
Pharmaceutical company Achillion Pharmaceuticals (NasdaqGS:ACHN) reported on Wednesday the completion of its public offering of 13,800,000 common stock at USD10.25 per share.
ACHN: 10.99 (-0.64)
Achillion completes equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 3:48PM CST
ACHN: 10.99 (-0.64)
Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock
GlobeNewswire - Wed Feb 18, 3:35PM CST
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today the closing of its previously announced public offering of common stock. Achillion sold 13,800,000 shares of its common stock in the offering at a price to the public of $10.25 per share, including the exercise in full by the underwriters of their option to purchase an additional 1,800,000 shares of common stock at the public offering price. Achillion received net proceeds of approximately $132.7 million, after deducting underwriting discounts and commissions and estimated offering expenses.
ACHN: 10.99 (-0.64), WFC: 54.84 (+0.02)
Is Gilead Sciences Inc. Stock Cheap Now?
George Budwell, The Motley Fool - Motley Fool - Wed Feb 18, 7:59AM CST
The stock market doesn't always make sense or act on rational terms. Sometimes good stocks are sold off for little or no reason. That appears to be the case with Gilead Sciences . Gilead's shares have tanked due to pricing pressure from AbbVie...
JNJ: 102.52 (+0.87), GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), PFE: 34.47 (-0.17), ABBV: 56.86 (-3.41), CELG: 120.71 (+1.14)
Hep C Franchise Will Remain Key Midterm Driver For Gilead
Kanak Kanti De - at Seeking Alpha - Tue Feb 17, 12:34PM CST
JNJ: 102.52 (+0.87), GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), ABBV: 56.86 (-3.41)
Achillion Pharmaceuticals: A Strong Contender In A Crowded Space
DoconStocks - at Seeking Alpha - Tue Feb 17, 7:53AM CST
GILD: 103.42 (+0.36), ACHN: 10.99 (-0.64), MRK: 57.98 (+0.10), ABBV: 56.86 (-3.41)
Emergent BioSolutions Reports Positive Data on BioThrax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 3:10PM CST
Emergent BioSolutions Inc. (EBS) announced encouraging data from a pivotal non-clinical efficacy study on BioThrax.
BMRN: 113.50 (+3.71), EBS: 29.24 (-0.24), ALNY: 111.56 (+4.33), ACHN: 10.99 (-0.64)
